Back to Directory
CanCan Diagnostics
Scotland
Founded 2022
NGS liquid biopsy testing for cancer in dogs and cats
CanCan Diagnostics is a veterinary biotechnology company developing next-generation sequencing tests for cancer detection and monitoring in companion animals.
Its K9 LiquiDx liquid biopsy analyses tumour-associated mutations in circulating cell-free DNA from canine blood samples. The company also offers tissue-based molecular testing and has expanded its diagnostic portfolio into feline oncology.
A University of Edinburgh spin-out, CanCan supplies molecular oncology tests to veterinary clinics and research groups.
Company Notes
Member of